Federation des caisses Desjardins du Quebec »

Kailera Therapeutics shares owned by Federation des caisses Desjardins du Quebec

Quarter-by-quarter ownership of Kailera Therapeutics shares owned by Federation des caisses Desjardins du Quebec from 13F filings

Historical chart of Federation des caisses Desjardins du Quebec investment in Kailera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kailera Therapeutics held by Federation des caisses Desjardins du Quebec consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kailera Therapeutics by Federation des caisses Desjardins du Quebec

Quarter filed Position value Share count Share price at filing
2026-06-30 $25k 1.2k 22.03

More positions owned by Federation des caisses Desjardins du Quebec

Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Bk Nova Cad (BNS)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Bank Of Montreal Cadcom (BMO)
Suncor Energy (SU)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Tc Energy Corp (TRP)
Manulife Finl Corp (MFC)
Canadian Natl Ry (CNI)
Enbridge (ENB)

View all positions for Federation des caisses Desjardins du Quebec

Top funds holding Kailera Therapeutics

Bain Capital Investors
Bain Capital Life Sciences Investors
Rtw Investments
Canada Pension Plan Investment Board
Atlas Venture Life Science Advisors
FMR
BlackRock
Citadel Advisors
Adage Capital Partners GP
Wellington Management Company
Royalty Pharma Sub-Manager
Siren
Vanguard Capital Management
Vanguard Portfolio Management
Geode Capital Management

View all funds holding Kailera Therapeutics